GAIL ECKHARDT to Protein Kinase Inhibitors
This is a "connection" page, showing publications GAIL ECKHARDT has written about Protein Kinase Inhibitors.
Connection Strength
0.192
-
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models. Anticancer Drugs. 2018 10; 29(9):827-838.
Score: 0.116
-
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug; 13(8):773-81.
Score: 0.076